Do troponins and natriuretic peptides help detect cancer therapy-induced cardiotoxicity in cardio-oncology patients?
Troponins and natriuretic peptides are important for detecting cardiotoxicity induced by cancer therapy.
Our data suggest that cardiac biomarkers play an important role in the detection of cancer therapy-induced cardiotoxicity. Larger systematic assessment in prospective cohorts is mandatory.
Hinrichs et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: